Skip to main content
Central European Journal of Urology logoLink to Central European Journal of Urology
. 2017 Sep 7;70(3):320. doi: 10.5173/ceju.2017.1506

A prospective evaluation of 3-D laparoscopic transperitoneal radical nephrectomy for large renal tumors (clinical stage T2N0M0): A single-centre, single-surgeon experience

Anup Kumar 1, Niraj Kumar 1, Gaurav Kumar 1,, Mikir Patel 1, Pankaj Gupta 1
PMCID: PMC5656373  PMID: 29123921

The aim of this study is to prospectively evaluate the feasibility, safety and long-term results of 3-D laparoscopic transperitoneal radical nephrectomy (LRN) of large renal tumors (clinical stage T2N0M0).

All consecutive patients undergoing 3-D laparoscopic radical nephrectomy (LRN) for a clinical stage T2N0M0 by a single surgeon between January 2011 and March 2016 at our institution were included. The various clinical data including patient's demographic profile, intraoperative and postoperative data, complications and follow-up were recorded and analyzed.

A total of 51 patients were included in the study. The mean tumor size was 7.9 cm. Limited hilar lymphadenectomy was performed in 38 (74.5%) patients. Concomitant lymphadenectomy was performed in 15 (29.4%) patients. The mean operating time and mean estimated blood loss were 179.3 min and 193.1 ml respectively. In 3 (5.8%) patients, conversion to open surgery was required. Blood transfusions were required in 5 (9.8%) patients. The mean hospital stay and mean convalescence period were 3.5 days and 1.49 weeks respectively. Intraoperative (5.8% – bleeding: 1, bowel injury: 1) and postoperative complications (7.8% – wound infection: 1, delayed bleeding: 1, atelectasis: 1, ileus: 1) were seen in 3 and 5 patients respectively. Renal cell carcinoma and oncocytoma were found on histopathological examination in 48 (94.1%) and 3 (5.9%) patients respectively. At the mean follow-up of 49.1 months, there were 2 distant metastases (brain – 1, lung – 1).The 5-year overall, cancer-specific and recurrence-free survival rates were 92.3%, 94.1% and 96.1% respectively.

The 3-D LRN for large renal tumors (clinical stage T2N0M0) is technically feasible, safe, and effective with good long-term survival outcomes. However, this technically challenging procedure should be attempted by surgeons of significant expertise.

CONFLICTS OF INTEREST

The authors declare no conflicts of interest.

Download video file (269.7MB, mp4)

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Download video file (269.7MB, mp4)

Articles from Central European Journal of Urology are provided here courtesy of Polish Urological Association

RESOURCES